Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.

Journalist and author Henry Grabar on NYC’s Congestion Pricing and how this could help the Democratic Party. Dr. Silviu Itescu, CEO at Mesoblast, on MESO stock soaring after FDA stem cell therapy approval. And we Drive to the Close with Tony Roth CIO at Wilmington Trust

Hosts:Carol Massar and Tim Stenovec. Producer: Paul Brennan and Sebastian Escobar

Watch Carol and Tim LIVE every day on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>. Journalist and author Henry Grabar on NYC&rsquo;s Congestion Pricing and how this could help the Democratic Party. Dr. Silviu Itescu, CEO at Mesoblast, on MESO stock soaring after FDA stem cell therapy approval. And we Drive to the Close with Tony Roth CIO at Wilmington Trust Hosts:Carol Massar and Tim Stenovec. Producer: Paul Brennan and Sebastian Escobar

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more. Watch us LIVE on YouTube: http://bit.ly/3vTiACF.

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more. Watch us LIVE on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors.

Bloomberg Businessweek

NYC Congestion Pricing, Stem Cell Therapy

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/20b96aab-f8d4-4b3a-a977-b25d015b5b0a/transcript

Advertisement